VSports - 2017
DOI: 10.1186/s40425-017-0298-2
|Get access via publisher |Cite
|
Sign up to set email alerts

Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer

Abstract: BackgroundHepatocellular carcinoma (HCC) is a major health problem worldwide with increasing incidence rates. As HCC traditionally occurs in chronically inflamed livers, this inflammation aids to drive oncogenesis and often renders these lesions to be immunogenic and therefore potential targets for immunotherapy. As patients with HCC generally have underlying liver dysfunction, we sought to determine if immune checkpoint inhibitors were safe to use in patients with HCC as compared to melanoma and non-small cel… Show more (V体育2025版)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
44
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations

Cited by 70 publications

(45 citation statements)
references

References 55 publications

(32 reference statements)
1
44
0
Order By: Relevance